| ID | Pathways | ARGs | Pathway genes |
| 5166 | HTLV-I infection | HLA-B, HLA-A | 3135, 3134 | 5168 | Herpes simplex infection | HLA-B, HLA-A | 3135, 3134 | 5169 | Epstein-Barr virus infection | HLA-B, HLA-A | 3135, 3134 | 5203 | Viral carcinogenesis | HLA-B, HLA-A | 3135, 3134 | 5416 | Viral myocarditis | HLA-B, HLA-A | 3135, 3134 | 4940 | Type I diabetes mellitus | HLA-B, HLA-A | 3135, 3134 | 5332 | Graft-versus-host disease | HLA-B, HLA-A | 3135, 3134 | 5320 | Autoimmune thyroid disease | HLA-B, HLA-A | 3135, 3134 | 5330 | Allograft rejection | HLA-B, HLA-A | 3135, 3134 | 5200 | Pathways in cancer | MYH9, ZNRD1 | 7428, 6772 | 5164 | Influenza A | IRF1, ZNRD1 | 356, 5609 | 5205 | Proteoglycans in cancer | MYH9, ZNRD1 | 5781, 5293 | 5152 | Tuberculosis | TLR8, ZNRD1 | 6772, 3587 | 5202 | Transcriptional misregulation in cancer | ZNRD1, MYH9 | 5371, 51513 | 5016 | Huntington’s disease | ZNRD1, TSG101 | 25981, 55567 | 5145 | Toxoplasmosis | MYH9, ZNRD1 | 2775, 4261 | 5161 | Hepatitis B | MYH9, ZNRD1 | 5111, 356 | 5162 | Measles | NCOR2, ZNRD1 | 356, 6772 | 5206 | MicroRNAs in cancer | MYH9, ZNRD1 | 7143, 6655 | 5160 | Hepatitis C | ZNRD1, GML | 6772, 6655 | 5010 | Alzheimer’s disease | NCOR2, ZNRD1 | 4035, 9377 |
|
|